Michael Buljan

Statistics

Publications

Citations

H-Index

Active since

2014

Affiliations

University of Washington(Current)

University of California, San Francisco

Michael Buljan is an author at University of Washington specializing in immunotherapy for skin cancer, antitumor t cell responses, and cytokine therapy.

Publications per year

2014–2015

Publications

Systemic antitumor effect and clinical response in a phase 2 trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma.

Adil Daud, Alain P. Algazi, Michelle T. Ashworth et al. · Journal of Clinical Oncology · 2014 · 27 citations

Medicine, Immunology, Oncology +17

Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)

Adil Daud, Alain P. Algazi, Michelle T. Ashworth et al. · Journal of Translational Medicine · 2015 · 11 citations · Full text

Medicine, Immunology, Oncology +17

1–2 of 2